Login / Signup

Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.

Toshiki HoriiSho SuzukiChika TakanoHitoshi ShibuyaRyoji IchijimaChika KusanoHisatomo IkeharaTakuji Gotoda
Published in: Journal of gastroenterology and hepatology (2021)
Compared with VAC-triple therapy, VA-dual therapy induced minimal changes in the diversity and relative abundance of gut microbiota.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • stem cells
  • oxidative stress
  • high glucose
  • diabetic rats
  • drug induced